Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Option Care Health (OPCH) over the last 16 years, with FY2024 value amounting to $64.5 million.

  • Option Care Health's Gains from Investment Securities fell 1866.74% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.2 million, marking a year-over-year increase of 707.52%. This contributed to the annual value of $64.5 million for FY2024, which is 1424.62% down from last year.
  • Latest data reveals that Option Care Health reported Gains from Investment Securities of $64.5 million as of FY2024, which was down 1424.62% from $75.2 million recorded in FY2023.
  • Over the past 5 years, Option Care Health's Gains from Investment Securities peaked at $75.2 million during FY2023, and registered a low of $3.3 million during FY2020.
  • Over the past 5 years, Option Care Health's median Gains from Investment Securities value was $13.4 million (recorded in 2022), while the average stood at $32.4 million.
  • As far as peak fluctuations go, Option Care Health's Gains from Investment Securities soared by 45991.22% in 2023, and later tumbled by 1424.62% in 2024.
  • Annual analysis of 5 years shows Option Care Health's Gains from Investment Securities stood at $3.3 million in 2020, then soared by 72.91% to $5.7 million in 2021, then skyrocketed by 135.51% to $13.4 million in 2022, then surged by 459.91% to $75.2 million in 2023, then dropped by 14.25% to $64.5 million in 2024.
  • Its Gains from Investment Securities stands at $64.5 million for FY2024, versus $75.2 million for FY2023 and $13.4 million for FY2022.